Nomura said that South Korea's weight loss drug boom may weaken the food service industry and further drag down the recovery in domestic demand. The bank's economist wrote in the report: “Increased spending on weight loss drugs and falling food orders pose new consumption risks. ”

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.